CHARBEL YOUNES: Open Payments
NPI 1811568975 · BELLINGHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 52 payments from 13 companies in 2025. Trend: 2023 $76 · 2024 $1,344 · 2025 $1,221
Food & beverage: $974Education: $247
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $263 |
| ABBVIE INC. | 12 | $171 |
| Regeneron Healthcare Solutions, Inc. | 5 | $169 |
| E.R. Squibb & Sons, L.L.C. | 6 | $151 |
| Organon LLC | 7 | $126 |
| GENZYME CORPORATION | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| Incyte Corporation | 2 | $59 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| PFIZER INC. | 1 | $28 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Sotyktu, COSENTYX, OPZELURA, Zoryve, VTAMA.
Industry payments across MA — which companies pay providers there.
